预防性治疗
干扰素
医学
病毒学
季节性流感
免疫学
2019年冠状病毒病(COVID-19)
内科学
疾病
传染病(医学专业)
作者
V M Gagarinova,G S Ignat'eva,L V Sinitskaia,А. М. Иванова,Mariana A. Rodina,A V Tur'eva
出处
期刊:PubMed
日期:1993-09-01
卷期号: (5): 40-3
被引量:17
摘要
In four controlled observations on the organized groups of students and industrial workers during the epidemics of influenza A in 1988-1989 Arbidol, a new chemopreparation, was found to be well tolerated and to produce a pronounced prophylactic effect when administered in a dose of 0.2 g (2 tablets of 0.1 g) daily for 10-18 days. After the 18-day prophylactic course of Arbidol the induction of serum interferon was found.
科研通智能强力驱动
Strongly Powered by AbleSci AI